SCHEMBL15720064

SCHEMBL15720064

FC(F)(F)c1nc2ccccn2c1Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.48
ADCY10 Q96PN6 1/20 0.47
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ADORA3 P0DMS8 3/20 0.39
ADORA2A P29274 2/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
AGTR1 P30556 1/20 0.38
AGTR2 P50052 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3047813 0.81 KDM4E (0.47) MMP12ADCY10HSD17B10KDM4EALDH1A1
SCHEMBL3048268 0.81 KDM4E (0.59) MMP12HSD17B10KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3047019 0.80 KDM4E (0.46) MMP12ADCY10HSD17B10KDM4EALDH1A1
SCHEMBL20798092 0.76 KDM4E (0.66) ADCY10HSD17B10KDM4EALDH1A1HPGD
SCHEMBL20798147 0.76 ADCY10 (0.56) ADCY10HSD17B10KDM4EALDH1A1HPGD
SCHEMBL21863415 0.74 HSD17B10 (0.51) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL20798250 0.73 CDK4 (0.45) MMP12ADCY10KDM4EALDH1A1GAA
SCHEMBL18100968 0.72 HSD17B10 (0.50) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10012248 0.72 HSD17B10 (0.50) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL3050995 0.72 ALDH1A1 (0.55) HSD17B10KDM4EALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3827820-A1 BRIVARACETAM FOR IMPROVING COGNITIVE FUNCTION The Johns Hopkins University (US) 2021-06-02 EP disclosed
EP-2968237-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION The Johns Hopkins University (US) 2016-01-20 EP disclosed
EP-2968220-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION Agenebio, Inc. (US) 2016-01-20 EP disclosed
EP-2968257-A1 METHODS AND COMPOSITONS FOR IMPROVING COGNITIVE FUNCTION The Johns Hopkins University (US) 2016-01-20 EP disclosed
EP-2919788-A1 METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA The Johns Hopkins University (US) 2015-09-23 EP disclosed
WO-2014144663-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION THE JOHNS HOPKINS UNIVERSITY (US) 2014-09-18 WO disclosed
WO-2014144546-A1 METHODS AND COMPOSITONS FOR IMPROVING COGNITIVE FUNCTION THE JOHNS HOPKINS UNIVERSITY (US) 2014-09-18 WO disclosed
WO-2014144801-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION AGENEBIO INC. (US) 2014-09-18 WO disclosed
WO-2014078568-A1 METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA THE JOHNS HOPKINS UNIVERSITY (US) 2014-05-22 WO disclosed